糖尿病肾病与炎性细胞因子的研究现状
-
-
[1] NAVARRO-GONZÁLEZ JF,MORA-FERNÁNDEZ C,MUROS DE FUENTES M,et al.Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy[J].Nat Rev Nephrol,2011,7(6):327. [2] SANCHEZ AP,SHARMA K.Transcription factors in the pathogenesis of diabetic nephropathy[J].Expert Rev Mol Med,2009,11(7):e13. [3] CUETO-MANZANO AM,CORTES-SANABRIA L,MARTINEZ-RAMIREZ HR,et al.Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus[J].Kidney Int Suppl,2005,107(9):S40. [4] NAVARRO-GONZÁLEZ JF,MORA-FERNÁNDEZ C.The role of inflammatory cytokines in diabetic nephropathy[J].J Am Soc Nephrol,2008,89(12):433. [5] MIN D,LYONS JG,BONNER.Mesanial cell-derived factorsalter monocyte activation and function through inflammatory unction through inflammatory pathways:possible pathogenic role in diabetic nephropathy[J].Am J Physiol Renal Physiol,2009,297(5):F1229. [6] EL MESALLAMY HO,AHMED HH,BASSYOUNI AA,et al.Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy[J].Clin Biochem,2012,75(4):646. [7] CUETO-MANZANO AM,CORTES-SANABRIA L,MARTINEZ-RAMIREZ HR,et al.Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus[J].Kidney Int Suppl,2005,89(9):S40. [8] CAO Z,COOPER ME.Pathogenesis of diabetic nephropathy[J].J Diabetes Invest,2011,66(2):243. [9] NAVARRO-GONZÁLEZ JF,JARQUE A,MUROS M,et al.Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy[J].Cytokine Growth Factor Rev,2009,20(4):165. [10] 马丽.炎症反应在糖尿病肾病发病中的作用研究进展[J/CD].中华临床医师杂志(电子版),2013,13(12):2076. [11] LOPEZ-PARRA V,MALLAVIA B,EGIDO J,et al.Immunoinflammation in Diabetic Nephropathy:Molecular Mechanisms and Therapeutic Options[M]//CHAN JS.Diabetic Nephropathy.InTech,Chapters,2012:127. [12] CHOW FY,NIKOLIC-PATERSON DJ,ATKINS RC,et al.Macrophages in streptozotocin-induced diabetic nephropathy:potential role in renal fibrosis[J].Nephrol Dial Transpl,2004,19(6):2987. [13] NGUYEN D,PING F,MU W,et al.Macrophage accumulation in human progressive diabetic nephropathy[J].Nephrology,2006,11(9):226. [14] XIAO X,MA B,DONG B,et al.Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice[J].J Autoimmun,2009,43(3):85. [15] MOON JY,JEONG KH,LEE TW,et al.Aberrant recruitment and activation of T cells in diabetic nephropathy[J].Am J Nephrol,2012,35(3):164. [16] LEI L,MAO Y,MENG D,et al.Percentage of circulating CD8+ T lymphocytes is associated with albuminuria in type 2 diabetes mellitus[J].Exp Clin Endocrinol Diabetes,2014,122(11):27. [17] TAKEBAYASHI K,MATSUMOTO S,ASO Y,et al.Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients[J].J Diabetes Complications,2006,20(12):98. [18] MORIYA R,MANIVEL JC,MAUER M.Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in Type 1 diabetic patients[J].Diabetologia,2004,47(1):82. [19] VIEDT C,ORTH SR.Monocyte chemoattractant protein-1(MCP-1)in the kidney:does it more than simply attract monocytes?[J].Nephrol Dial Transplant,2002,17(12):2043. [20] CHOW F,OZOLS E,NIKOLIC-PATERSON DJ.Macrophages in mouse type 2 diabetic nephropathy:correlation with diabetic state and progressive renal injury[J].Kidney Int,2004,65(1):116. [21] VESEY DA,CHEUNG C,CUTTLE L,et al.Interleukin-1βstimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-β-dependent mechanism[J].J Lab Clin Med,2002,140(4):342. [22] 张巍,于为民,任小军.糖尿病肾病的炎症反应[J].中国现代医生,2014,52(9):157. [23] ASO Y,YOSHIDA N,OKUMURA KI,et al.Coagulation and inflammation in overt diabetic nephropathy:association with hyperhomocysteinemia[J].Clin Chim Acta,2004,348(2):139. [24] NAKAMURA A,SHIKATA K,HIRAMATSU M,et al.Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes[J].Diabetes Care,2005,78(2):2890. [25] DAI SM,MATSUNO H,NAKAMURA H.Interleukin-18 enhances monocyte tumor necrosis factorαand interleukin-1β production induced by direct contact with T lymphocytes:implications in rheumatoidarthritis[J].Arthritis Rheum,2004,50(5):432. [26] RUBIO-GUERRA AF,VARGAS-ROBLES H,VARGAS-AYALA G,et al.The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes[J].Clin Exp Hypertens,2008,60(3):682. [27] LETTERIO JJ,ROBERTS AB.Regulation of immune responses by TGF-β[J].Annu Rev Immunol,1998,16(5):137. [28] SERON D,CAMERON JS,HASKARD DO.Expression of VCAM-1 in the normal and diseased kidney[J].Nephrol Dial Transplant,1991,34(6):917. [29] LAN HY.Diverse roles of TGF-β/Smads in renal fibrosis and inflammation[J].Int J Biol Sci,2011,56(7):1056. [30] DERYNCK R,ZHANG YE.Smad-dependent and Smad-independent pathways in TGF-β family signaling[J].Nature,2003,6958(5):577. [31] RUBIO-GUERRA AF,CABRERA-MIRANDA LJ,VARGAS-ROBLES H,et al.Correlation between levels of circulating adipokines and adiponectin/resistin index with carotid intima-media thickness in hypertensive type 2 diabetic patients[J].Cardiology,2013,12(5):150. [32] SHARMA K,RAMACHANDRARAO S,QIU G,et al.Adiponectin regulates albuminuria and podocyte function in mice[J].J Clin Invest,2008,10(118):1645. [33] ELLINGTON AA,MALIK AR,KLEE GG,et al.Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults[J].Hypertension,2007,10(5):708. [34] LOZANO-NUEVO JJ,ESTRADA-GARCIA T,VARGAS-ROBLES H,et al.Correlation between circulating adhesion molecules and resistin levels in hypertensive type-2 diabetic patients[J].Inflamm Allergy Drug Targets,2011,10(5):27.
点击查看大图
计量
- 文章访问数: 3313
- HTML全文浏览量: 360
- PDF下载量: 168
- 被引次数: 0